Augmentation of the in vitro humoral immune response by pharmacologic agents. II: Comparison of the effects of antiproliferative agents with DBcAMP-Reference-Cited by-同舟云学术

Augmentation of the in vitro humoral immune response by pharmacologic agents. II: Comparison of the effects of antiproliferative agents with DBcAMP

Published:1979-03 Issue:2 Volume:1 Page:151-163
ISSN:0162-3109
Container-title:Immunopharmacology
language:en
Short-container-title:Immunopharmacology

Author:

Burchiel Scott W.,Melmon Kenneth L.

Publisher

Elsevier BV

Subject

Pharmacology

Reference46 articles.

1. Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide that do not affect antibody synthesis;Askenase;J Exp Med,1975

2. The suppressive effect of immunization on the proliferation responses of rat cells in vitro II. Abrogation of antigen-induced suppression by selective cytotoxic agents;Bash;J Immunol,1976

3. Modulation of inflammation and immunity by cyclic AMP;Bourne;Science,1974

4. Cytotoxic test for mouse antibody;Boyse,1964

5. Augmentation of the in vitro humoral response by pharmacologic agents I: An explanation for the differential enhancement of humoral immunity via agents that elevate cAMP;Burchiel;Immunopharmacology,1979

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of the Murine and Human Immune System: Differential Effects of Immunotoxicants Depend on Time of Exposure;Environmental Health Perspectives;2000-06

2. Development of the murine and human immune system: differential effects of immunotoxicants depend on time of exposure.;Environmental Health Perspectives;2000-06

3. The Role of Brain-Immune Interactions in Immunotoxicology;Critical Reviews in Toxicology;1994-01

4. Analysis of heavy metal immunotoxicity by multiparameter flow cytometry: Correlation of flow cytometry and immune function data in B6CF1 mice;International Journal of Immunopharmacology;1987-01

5. Increase of natural killer (NK) activity of mouse lymphocytes following in vitro treatment with cytosine-arabinoside;International Journal of Immunopharmacology;1984-01